Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer vaccine

In partnership with CEL-SCI Corporation, Northeast Ohio Medical University (NEOMED) has produced a new investigational breast cancer vaccine. In animal tests the J-HER vaccine has shown reduction of HER-2/neu expressing breast cancer tumors, reduction mass, absence of tumor in lymph nodes or peritoneal membranes, and changes in angiogenesis.

Dr. Rosenthal, Sarah Stone and Robin Edmonds from NEOMED worked with CEL-SCI’s Dr. Daniel Zimmerman to design and test the LEAPS (Ligand Epitope Antigen Presentation System) technology vaccine. 

Present in most human breast tumor cells, the HER-2/neu protein is the target for different types of immunotherapy with sales of many billions of dollars.  Blocking this receptor protein with an antibody causes the tumor cells to commit suicide, or apoptosis. The J-HER vaccine activates a T lymphocyte response targeted to this protein that promotes killing and control of the tumor cell. In these studies, mice were immunized with the vaccine before, or one week after implantation of HER-2/neu breast cancer cells. In both cases the immune response initiated by the immunization significantly blocked further development and progression of tumors in most of the animals.

More details on the vaccine and technology available here.

NEOMED is located in Rootstown, Ohio. CEL-SCI has operations in Vienna, Virginia, and Baltimore, Maryland.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


Ethicon develops the suture of the future at €80 million Limerick, Ireland plant | Limerick Leader, April 16, 2014

Mahoning County Educational Service Center to open a new STEM academy targeting ninth and tenth graders | WKBN27 News, April 16, 2014

Vorys law firm plans to move downtown Cleveland offices to 200 Public Square | Cleveland.com, April 15, 2014

UC researchers ‘touch’ discovery could help pain disorders | Cincinnati Business Courier, April 15, 2014

University of Cincinnati College of Law partners with HCBC and First Batch to aid start-ups with legal help | Cincinnati Business Courier, April 15, 2014

Great Lakes NeuroTechnologies awarded $1.5M NIH funding to expand Parkinson’s telemedicine to mobile aps | Great Lakes NeuroTechnologies, April 15, 2014

Cardinal Health announces an annual $600K OSU College of Pharmacy Scholarship | Ohio State University, April 14, 2014

State legislation, funding would create pilot program to help students in STEM fields | The News-Herald, April 14, 2014

Nationwide Children’s Hospital: Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in children | Nationwide Children's Hospital, April 14, 2014

Akebia Therapeutics’ stock soars this Monday with optimistic analysts’ reports | Cincinnati Business Courier, April 14, 2014

Dayton Children’s pediatric neurology team nationally designated as a Level 3 Epilepsy Center | PR Web, April 14, 2014

Cedarville University School of Pharmacy partnering with regional hospitals | Xenia Gazette, April 14, 2014

Cleveland biomedical industry spotlight, featuring Simbionix | Cleveland.com, April 13, 2014

2014 Innovation Award presented to Assurex Health | Cincinnati Business Courier, April 12, 2014

Freshwater Cleveland interviews Dr. Stanton Gerson of Case Comprehensive Cancer Center, National Center for Regenerative Medicine, and Seidman Cancer Hospital at University Hospitals CMC | Freshwater Cleveland, April 10, 2014

AmerisourceBergen CEO, Governor Kasich kick off construction of the company’s new pharmaceutical distribution center in Columbus | Columbus CEO, April 9, 2014

Sinclair Community College recognized for Exemplary Board/CEO by the American Association of Community Colleges | Digital Journal, April 9, 2014

CWRU grad wins $100,000 in national business competition for malaria diagnosis device | Cleveland.com, April 9, 2014

Medical Mutual of Ohio awards $750k grant to NorTech to support regional growth | Crain's Cleveland Business, April 8, 2014

An interview with Gina Drosos, Assurex Health’s new President | Cincinnati Business Courier, April 8, 2014